0597-7705 : Spevigo 300 mg/2ml Intravenous Injection
| NDC: | 0597-7705 |
| Labeler: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Spevigo |
| Dosage Form: | Intravenous Injection |
| Application #: | BLA761244 |
| Rev. Date: |
NDC Package Codes:
- 0597-7705-41: 1 SYRINGE IN 1 CARTON (0597‑7705‑41) / 300 ML IN 1 SYRINGE (0597‑7705‑38)
- 0597-7705-72: 2 SYRINGE IN 1 CARTON (0597‑7705‑72) / 300 ML IN 1 SYRINGE (0597‑7705‑38)
Active Ingredients:
- Spesolimab
Dosage Strength:
- 300 mg/2mL
Pharmaceutical Classes:
- Interleukin-36 Receptor Antagonist [EPC]
- Interleukin-36 Receptor Antagonists [MoA]
Related Products:
Based on records with the same trade name.- 0597-0035 Spevigo 60 mg/ml Intravenous Injection by Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0620 Spevigo 150 mg/ml Intravenous Injection by Boehringer Ingelheim Pharmaceuticals, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0597-0620Next: 0597-9257 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.